Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

X4 Pharmaceuticals (XFOR) Debt Ratio (2018 - 2023)

X4 Pharmaceuticals' Debt Ratio history spans 5 years, with the latest figure at 0.0 for Q2 2023.

  • For Q2 2023, Debt Ratio fell 95.85% year-over-year to 0.0; the TTM value through Jun 2023 reached 0.0, down 95.85%, while the annual FY2022 figure was 0.01, 24.57% up from the prior year.
  • Debt Ratio reached 0.0 in Q2 2023 per XFOR's latest filing, down from 0.0 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.2 in Q2 2019 to a low of 0.0 in Q2 2023.
  • Average Debt Ratio over 4 years is 0.06, with a median of 0.02 recorded in 2022.
  • Peak YoY movement for Debt Ratio: surged 2142.11% in 2022, then tumbled 95.85% in 2023.
  • A 4-year view of Debt Ratio shows it stood at 0.2 in 2019, then crashed by 96.56% to 0.01 in 2021, then increased by 24.57% to 0.01 in 2022, then tumbled by 47.87% to 0.0 in 2023.
  • Per Business Quant, the three most recent readings for XFOR's Debt Ratio are 0.0 (Q2 2023), 0.0 (Q1 2023), and 0.01 (Q4 2022).